Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 9,002,632 12.170% | 14,223 (+0.16%) | Filing History |
| 2024-01-24 5:23 pm Sale | 2023-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 7,778,203 10.500% | -370,421 (-4.55%) | Filing History |
| 2023-02-14 12:37 pm Sale | 2022-12-31 | 13G | West Pharmaceutical Services, Inc. WST | T. Rowe Price Associates, Inc. | 2,301,161 3.100% | -3,940,740 (-63.13%) | Filing History |
| 2023-02-09 11:37 am Purchase | 2022-12-30 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 8,988,409 12.140% | 354,556 (+4.11%) | Filing History |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 8,148,624 11.000% | 54,336 (+0.67%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | T. Rowe Price Associates, Inc. | 6,241,901 8.400% | 1,617,654 (+34.98%) | Filing History |
| 2022-02-10 08:47 am Purchase | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 8,633,853 11.650% | 344,483 (+4.16%) | Filing History |
| 2022-02-04 11:53 am Sale | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | FRANKLIN RESOURCES INC BEN | 2,848,869 3.800% | -1,005,409 (-26.09%) | Filing History |
| 2022-01-26 8:18 pm Unchanged | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 8,094,288 10.900% | 0 (Unchanged) | Filing History |
| 2022-01-25 11:15 am Purchase | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 8,094,288 10.900% | 626,479 (+8.39%) | Filing History |
| 2021-04-09 6:02 pm Purchase | 2021-03-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 7,467,809 10.100% | 176,869 (+2.43%) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | West Pharmaceutical Services, Inc. WST | T. Rowe Price Associates, Inc. | 4,624,247 6.200% | -2,206,742 (-32.30%) | Filing History |
| 2021-02-10 12:00 pm Purchase | 2020-12-31 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 8,289,370 11.210% | 790,257 (+10.54%) | Filing History |
| 2021-02-02 3:14 pm Sale | 2020-12-31 | 13G | West Pharmaceutical Services, Inc. WST | FRANKLIN RESOURCES INC BEN | 3,854,278 5.200% | -591,322 (-13.30%) | Filing History |
| 2021-02-01 08:30 am Sale | 2020-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 7,290,940 9.900% | -867,980 (-10.64%) | Filing History |